首页
数据库
关于我们
联系我们
您当前的位置： 首页 > 数据库
所属年份
2008 2017 2018 2019 2020 2021 2022 2023 2024
到
2008 2017 2018 2019 2020 2021 2022 2023 2024
检索 清除
手术分类
  • 全部（1880）
  • 腹部手术（323）
  • 胸科手术（41）
  • 血管手术（5）
  • 心脏手术（56）
  • 神经外科（4）
  • 头颈部（35）
  • 骨科（78）
  • 泌尿外科（0）
  • 妇产手术（56）
  • 日间手术（26）
  • 手术室外（0）
  • 创伤和烧伤（0）
  • 非心脏手术（410）
  • 老年（0）
  • 小儿新生儿（126）
  • 特殊患者（42）
  • 未说明手术类型（678）
阶段管理
  • 术前宣教（21）
  • 术前评估（33）
  • 术前用药（15）
  • 术前禁食水（12）
  • 麻醉选择（21）
  • 麻醉用药（10）
  • 术中监测（23）
  • 液体管理（14）
  • 血液保护（3）
  • 体温管理（8）
  • 术后疼痛（43）
  • POD（8）
  • PONV（10）
  • 术后康复（50）
  • 特殊情况（43）
  • 术前肠道准备（9）
排序：
发表时间 阅读量
Array ( [id] => 2226 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2226.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In patients with diabetes or disturbed glucose metabolism, a pre-operative HbA1c test is recommended, if this measurement has been not performed in the previous 3 months. In case of HbA1c ≥8.5% (≥69 mmol/mol), elective NCS should be postponed, if safe and practical.(Evidence: Level B，Recommendation: Class I) [laiyuan] => 建议术前3个月未行糖化血红蛋 白（HbA1c）检查的 DM 或糖代谢紊乱患者，术前行HbA1c检查。如果术前 HbA1c ≥8.5%（≥ 69 mmol/mol），建议综合评估患者安全及可行性后暂缓择期 NCS。（证据级别：B；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
建议术前3个月未行糖化血红蛋 白（HbA1c）检查的 DM 或糖代谢紊乱患者，术前行HbA1c检查。如果术前 HbA1c ≥8.5%（≥ 69 mmol/mol），建议综合评估患者安全及可行性后暂缓择期 NCS。（证据级别：B；推荐强度：I）

In patients with diabetes or disturbed glucose metabolism, a pre-operative HbA1c test is recommended, if this measurement has been not performed in the previous 3 months. In case of HbA1c ≥8.5% (≥69 mmol/mol), elective NCS should be postponed, if safe and practical.(Evidence: Level B，Recommendation: Class I)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2227 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2227.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => A pre-operative assessment for concomitant cardiac conditions is recommended in patients with diabetes with suspected or known CAD, and those with autonomic neuropathy, retinopathy, or renal disease and scheduled to undergo intermediateor high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 对于患有DM+疑似/确诊CAD或自主神经病变、视网膜病变或肾脏疾病且拟行中-高风险NCS的患者，术前应同时行心血管评估.（证据级别：C；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
对于患有DM+疑似/确诊CAD或自主神经病变、视网膜病变或肾脏疾病且拟行中-高风险NCS的患者，术前应同时行心血管评估.（证据级别：C；推荐强度：I）

A pre-operative assessment for concomitant cardiac conditions is recommended in patients with diabetes with suspected or known CAD, and those with autonomic neuropathy, retinopathy, or renal disease and scheduled to undergo intermediateor high-risk NCS.(Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2228 [catid] => 197 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2228.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In order to preserve optimal CV stability, it is recommended to apply goal-directed haemodynamic therapy in patients undergoing high-risk NCS.(Evidence: Level A ，Recommendation: Class I) [laiyuan] => 为维持高风险患者心血管系统的稳定，建议实施目标导向的血流动力学管理。（证据级别：A；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
为维持高风险患者心血管系统的稳定，建议实施目标导向的血流动力学管理。（证据级别：A；推荐强度：I）

In order to preserve optimal CV stability, it is recommended to apply goal-directed haemodynamic therapy in patients undergoing high-risk NCS.(Evidence: Level A ，Recommendation: Class I)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2229 [catid] => 200 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2229.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => It is recommended to avoid post-operative acute pain.(Evidence: Level B，Recommendation: Class I) [laiyuan] => 建议积极防治术后急性疼痛。（证据级别：B；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
建议积极防治术后急性疼痛。（证据级别：B；推荐强度：I）

It is recommended to avoid post-operative acute pain.(Evidence: Level B，Recommendation: Class I)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2230 [catid] => 196 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2230.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In order to minimize the risk of post-operative organ dysfunction, it is recommended to avoid an intra-operative mean arterial pressure decrease of .20% from baseline values or,60–70 mmHg for ≥10 min.(Evidence: Level B，Recommendation: Class I) [laiyuan] => 为降低术后器官功能不全的风险，建议避免术中平均动脉压相较基线值降低超过20%，或MAP低于60～70 mmHg且持续时间 ≥ 10 min。（证据级别：B；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
为降低术后器官功能不全的风险，建议避免术中平均动脉压相较基线值降低超过20%，或MAP低于60～70 mmHg且持续时间 ≥ 10 min。（证据级别：B；推荐强度：I）

In order to minimize the risk of post-operative organ dysfunction, it is recommended to avoid an intra-operative mean arterial pressure decrease of .20% from baseline values or,60–70 mmHg for ≥10 min.(Evidence: Level B，Recommendation: Class I)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2231 [catid] => 200 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2231.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Non-aspirin NSAIDs are not recommended as first-line analgesics in patients with established or high risk of CVD.(Evidence: Level B，Recommendation: Class III) [laiyuan] => 对于己经存在或心血管疾病高风险的患者，不建议将非阿司匹林的NSAIDS作为一线镇痛药。（证据级别：B；推荐强度：III） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
对于己经存在或心血管疾病高风险的患者，不建议将非阿司匹林的NSAIDS作为一线镇痛药。（证据级别：B；推荐强度：III）

Non-aspirin NSAIDs are not recommended as first-line analgesics in patients with established or high risk of CVD.(Evidence: Level B，Recommendation: Class III)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2232 [catid] => 312 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2232.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => It is recommended to have high awareness of peri-operative CV complications, combined with surveillance for PMI in patients undergoing intermediate- or high-risk NCS. (Evidence: Level B，Recommendation: Class I) [laiyuan] => 建议中-高风险患者行非心脏手术时应高度重视围术期心血管并发症及监测心肌梗死。（证据级别：B；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
建议中-高风险患者行非心脏手术时应高度重视围术期心血管并发症及监测心肌梗死。（证据级别：B；推荐强度：I）

It is recommended to have high awareness of peri-operative CV complications, combined with surveillance for PMI in patients undergoing intermediate- or high-risk NCS. (Evidence: Level B，Recommendation: Class I)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2233 [catid] => 312 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2233.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Systematic PMI work-up is recommended to identify the underlying pathophysiology and define therapy. (Evidence: Level B，Recommendation: Class Ⅰ) [laiyuan] => 建议开展全面系统检查以明确围手术期心肌梗死的病理生理并确定治疗方案。（证据级别：B；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
建议开展全面系统检查以明确围手术期心肌梗死的病理生理并确定治疗方案。（证据级别：B；推荐强度：I）

Systematic PMI work-up is recommended to identify the underlying pathophysiology and define therapy. (Evidence: Level B，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2234 [catid] => 312 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2234.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => It is recommended to treat post-operative STEMI, NSTE-ACS, acute HF, and tachyarrhythmias in accordance with guidelines for the non-surgical setting, after interdisciplinary discussion with the surgeon about bleeding risk. (Level of evidence：C；Class of recommendation：I） [laiyuan] => 一旦患者发生术后ST段抬高性心肌梗死、非ST段抬高急性冠脉综合征、急性心力衰竭和快速心律失常，建议先进行多学科讨论，再参照NCS 指南的相关建议实施治疗。（证据级别：C；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
一旦患者发生术后ST段抬高性心肌梗死、非ST段抬高急性冠脉综合征、急性心力衰竭和快速心律失常，建议先进行多学科讨论，再参照NCS 指南的相关建议实施治疗。（证据级别：C；推荐强度：I）

It is recommended to treat post-operative STEMI, NSTE-ACS, acute HF, and tachyarrhythmias in accordance with guidelines for the non-surgical setting, after interdisciplinary discussion with the surgeon about bleeding risk. (Level of evidence：C；Class of recommendation：I）

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读
Array ( [id] => 2235 [catid] => 312 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2235.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:43 [updatetime] => 2024-12-19 09:42:43 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In patients with post-operative PE of high or intermediate clinical probability, initiation of anticoagulation is recommended without delay, while diagnostic work-up is in progress, if bleeding risk is low. (Evidence: Level C，Recommendation: Class Ⅰ) [laiyuan] => 一旦临床怀疑低出血风险的患者发生术后肺栓塞，建议立即开始抗凝治 疗、同时行全面诊断性检查。（证据级别：C；推荐强度：I） [znzldj] => A [_inputtime] => 1734572563 [_updatetime] => 1734572563 [_nrjc] => [_nrsh] => )
推荐意见
一旦临床怀疑低出血风险的患者发生术后肺栓塞，建议立即开始抗凝治 疗、同时行全面诊断性检查。（证据级别：C；推荐强度：I）

In patients with post-operative PE of high or intermediate clinical probability, initiation of anticoagulation is recommended without delay, while diagnostic work-up is in progress, if bleeding risk is low. (Evidence: Level C，Recommendation: Class Ⅰ)

证据评价方法：LOE

指南质量等级：A

年份：2022

国家：the European Society of Anaesthesiology and Intens

来源 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
原文链接
阅读

地址：甘肃省兰州市七里河区瓜州路418号

邮编：730050

电话：0931-2687109

商务合作热线：0931-2687106

备案号：陇ICP备17005383号-1 联网备案号：62010302000288

技术支持：瑞秀科技